Home > Balance Sheet > VENUS REMEDIES

VENUS REMEDIES
Total Non-Current Liabilities

    Back to Balance Sheet
COMMUNITY POLL
for VENUS REMEDIES
Please provide your vote to see the results

VENUS REMEDIES Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Total Non-Current Liabilities ₹60 Cr₹58 Cr₹46 Cr₹58 Cr₹96 Cr

What is the latest Total Non-Current Liabilities ratio of VENUS REMEDIES ?

The latest Total Non-Current Liabilities ratio of VENUS REMEDIES is ₹60 Cr based on Mar2024 Consolidated results.
Year Total Non-Current Liabilities
Mar2024₹60 Cr
Mar2023₹58 Cr
Mar2022₹46 Cr
Mar2021₹58 Cr
Mar2020₹96 Cr

How is Total Non-Current Liabilities of VENUS REMEDIES Trending?

Years Total Non-Current Liabilities % Change
Mar2024 ₹60 Cr
2.89
Mar2023 ₹58 Cr
26.60
Mar2022 ₹46 Cr
-20.94
Mar2021 ₹58 Cr
-39.34
Mar2020 ₹96 Cr -

Compare Total Non-Current Liabilities of peers of VENUS REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VENUS REMEDIES ₹407.9 Cr 0.9% -7.7% -19.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹419,764.0 Cr -0.9% -4.8% 50.2% Stock Analytics
DIVIS LABORATORIES ₹159,306.0 Cr 3% 5.9% 65% Stock Analytics
CIPLA ₹120,459.0 Cr 1.5% 0.1% 19.9% Stock Analytics
DR REDDYS LABORATORIES ₹100,168.0 Cr -0.4% -8.2% 7.1% Stock Analytics
ZYDUS LIFESCIENCES ₹95,662.7 Cr 0.6% -5.3% 51% Stock Analytics


VENUS REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
VENUS REMEDIES

0.9%

-7.7%

-19.9%

SENSEX

3.4%

0.2%

21.7%


You may also like the below Video Courses